论文信息 - Requirements for a lead compound to become a clinical candidate - 字舞流文

Requirements for a lead compound to become a clinical candidate

[1] A. Camm,et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. , 2003, Cardiovascular research.

[2] Jürgen Bajorath,et al. Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.

[3] David H. Miller,et al. A controlled trial of natalizumab for relapsing multiple sclerosis. , 2003, The New England journal of medicine.

[4] K. Mohanakumar. Drug Discovery for Nervous System Diseases. John Wiley & Sons Inc., Hoboken, New Jersey, USA (2005), Paperback, Price: GB£ 48.95, ISBN: 0-471-46563-1 , 2006 .

[5] P. Leeson,et al. A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.

[6] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.